KR20040018314A - 게피론을 함유하는 경구 투여용 연장 방출형 제제 - Google Patents

게피론을 함유하는 경구 투여용 연장 방출형 제제 Download PDF

Info

Publication number
KR20040018314A
KR20040018314A KR10-2003-7007555A KR20037007555A KR20040018314A KR 20040018314 A KR20040018314 A KR 20040018314A KR 20037007555 A KR20037007555 A KR 20037007555A KR 20040018314 A KR20040018314 A KR 20040018314A
Authority
KR
South Korea
Prior art keywords
amount
gepirone
present
weight
hydrochloride
Prior art date
Application number
KR10-2003-7007555A
Other languages
English (en)
Korean (ko)
Inventor
에그베링크요하네스제라르두스요셉
엔젤하트죤프랑시스
Original Assignee
악조 노벨 엔.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 악조 노벨 엔.브이. filed Critical 악조 노벨 엔.브이.
Publication of KR20040018314A publication Critical patent/KR20040018314A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR10-2003-7007555A 2000-12-08 2001-11-30 게피론을 함유하는 경구 투여용 연장 방출형 제제 KR20040018314A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00204388.3 2000-12-08
EP00204388 2000-12-08
PCT/EP2001/014189 WO2002045753A2 (en) 2000-12-08 2001-11-30 Oral extended release formulation of gepirone

Publications (1)

Publication Number Publication Date
KR20040018314A true KR20040018314A (ko) 2004-03-03

Family

ID=8172397

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7007555A KR20040018314A (ko) 2000-12-08 2001-11-30 게피론을 함유하는 경구 투여용 연장 방출형 제제

Country Status (19)

Country Link
EP (1) EP1343504A2 (hu)
JP (1) JP2004517083A (hu)
KR (1) KR20040018314A (hu)
CN (1) CN1479620A (hu)
AR (1) AR031461A1 (hu)
AU (1) AU2002226371A1 (hu)
BR (1) BR0115976A (hu)
CA (1) CA2436692A1 (hu)
CZ (1) CZ20031589A3 (hu)
EC (1) ECSP034627A (hu)
HU (1) HUP0401021A2 (hu)
IL (1) IL155855A0 (hu)
MX (1) MXPA03005099A (hu)
NO (1) NO20032581L (hu)
PL (1) PL362445A1 (hu)
RU (1) RU2003120446A (hu)
SK (1) SK6942003A3 (hu)
WO (1) WO2002045753A2 (hu)
ZA (1) ZA200303915B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1545469A1 (en) * 2002-09-24 2005-06-29 Akzo Nobel N.V. Method to improve pharmaceutical tablets having a matrix of cellulose ether
BRPI0419179A (pt) * 2004-11-05 2007-12-18 Fabre Kramer Pharmaceuticals I formulação de alta dosagem de liberação prolongada de gepirona
MY198454A (en) * 2017-07-26 2023-08-29 Abbott Lab Nutritional Tablets and Methods of Making the Same
CN109745323A (zh) * 2017-11-01 2019-05-14 四川科瑞德制药股份有限公司 氮哌酮类化合物提高副交感神经活性的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form

Also Published As

Publication number Publication date
AR031461A1 (es) 2003-09-24
NO20032581D0 (no) 2003-06-06
HUP0401021A2 (hu) 2004-09-28
EP1343504A2 (en) 2003-09-17
WO2002045753A2 (en) 2002-06-13
JP2004517083A (ja) 2004-06-10
ECSP034627A (es) 2004-09-28
CN1479620A (zh) 2004-03-03
SK6942003A3 (en) 2003-10-07
PL362445A1 (en) 2004-11-02
CZ20031589A3 (cs) 2003-11-12
ZA200303915B (en) 2004-08-20
RU2003120446A (ru) 2005-02-20
IL155855A0 (en) 2003-12-23
AU2002226371A1 (en) 2002-06-18
NO20032581L (no) 2003-06-06
MXPA03005099A (es) 2004-02-12
BR0115976A (pt) 2003-12-30
WO2002045753A3 (en) 2002-08-29
CA2436692A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
EP0914119B1 (en) Process for forming solid oral dosage forms of valsartan
EP1468679B1 (en) Controlled release formulation containing tramadol
DE60221691T2 (de) Tamsulosin tabletten ohne nahrungsmitteleffekt
US6103263A (en) Delayed pulse release hydrogel matrix tablet
KR20060033727A (ko) 메만틴 경구 투여 제형
NZ272855A (en) Sustained release formulation comprising a cellulosic polymer matrix and gepirone
US20110196032A1 (en) Pharmaceutical Dosage Form of an Antidepressant
CA2493593A1 (en) Bicifadine formulation
KR20040018314A (ko) 게피론을 함유하는 경구 투여용 연장 방출형 제제
US11878078B2 (en) Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
US20030152621A1 (en) Pharmaceutical formulation of gepirone for oral administration
KR20180036579A (ko) 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
EP0106028A2 (en) Novel diuretic/antihypertensive compositions and methods of preparation
US20070087055A1 (en) Directly compressible extended release alprazolam formulation
CN108721241A (zh) 一种包含缬沙坦和氨氯地平的固体组合物及其制备方法
KR20010075385A (ko) (2ｓ,3ｓ,5ｒ)-2-(3,5-디플루오로페닐)-3,5-디메틸-2-모르폴린올 및 안정화 유효량의 알긴산을 포함하는 경구 투여 제제
KR20050085386A (ko) 불안증 치료 방법 및 조성물
KR20070093972A (ko) 게피론의 고용량 서방성 제제

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid